FDA Demonizing Vape Industry with the Ban of Juul Products
23 juin 2022 11h51 HE
|
The Blinc Group
New York, June 23, 2022 (GLOBE NEWSWIRE) -- According to the Wall Street Journal, the Food and Drug Administration could order Juul to take its e-cigarettes off the U.S. market as early as this...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
21 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
01 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
26 mai 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
13 mai 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
12 mai 2022 16h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
21 avr. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...
Global Dry Powder Inhalation Market Developments and Products Report 2022: Focus on Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances - Canceled, Under-Development, Clinical Trials
11 avr. 2022 04h33 HE
|
Research and Markets
Dublin, April 11, 2022 (GLOBE NEWSWIRE) -- The "Dry Powder Inhalation Developments and Products In Scope of Nicotine, Cannabinoids, Botanicals and Other Non-Medical Substances Delivery, Designed By...
VPR Brands Announces Favorable Settlement of Third Patent Infringement Case; Settlements Now Total Over $500,000
25 mars 2022 07h45 HE
|
VPR Brands LP
FORT LAUDERDALE, Fla., March 25, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- VPR Brands, LP (OTC: VPRB): VPR Brands is a market leader and pioneer in electronic cigarettes and vaporizers for...
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
15 mars 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 15, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development...